KR102211077B9 - - A pseudo type rabies virus vaccine using virus-like particles - Google Patents

- A pseudo type rabies virus vaccine using virus-like particles

Info

Publication number
KR102211077B9
KR102211077B9 KR20190005864A KR20190005864A KR102211077B9 KR 102211077 B9 KR102211077 B9 KR 102211077B9 KR 20190005864 A KR20190005864 A KR 20190005864A KR 20190005864 A KR20190005864 A KR 20190005864A KR 102211077 B9 KR102211077 B9 KR 102211077B9
Authority
KR
South Korea
Prior art keywords
virus
particles
pseudo type
vaccine
type rabies
Prior art date
Application number
KR20190005864A
Other languages
Korean (ko)
Other versions
KR102211077B1 (en
KR20200089151A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to KR1020190005864A priority Critical patent/KR102211077B1/en
Publication of KR20200089151A publication Critical patent/KR20200089151A/en
Application granted granted Critical
Publication of KR102211077B1 publication Critical patent/KR102211077B1/en
Publication of KR102211077B9 publication Critical patent/KR102211077B9/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16723—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020190005864A 2019-01-16 2019-01-16 A pseudo type rabies virus vaccine using virus-like particles KR102211077B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020190005864A KR102211077B1 (en) 2019-01-16 2019-01-16 A pseudo type rabies virus vaccine using virus-like particles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190005864A KR102211077B1 (en) 2019-01-16 2019-01-16 A pseudo type rabies virus vaccine using virus-like particles

Publications (3)

Publication Number Publication Date
KR20200089151A KR20200089151A (en) 2020-07-24
KR102211077B1 KR102211077B1 (en) 2021-02-02
KR102211077B9 true KR102211077B9 (en) 2021-02-02

Family

ID=71892827

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190005864A KR102211077B1 (en) 2019-01-16 2019-01-16 A pseudo type rabies virus vaccine using virus-like particles

Country Status (1)

Country Link
KR (1) KR102211077B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113559254B (en) * 2021-08-09 2023-02-10 苏州大学 Rabies virus vaccine and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2817005C (en) * 2010-11-05 2018-09-11 Novavax Inc. Rabies glycoprotein virus-like particles (vlps)
MY166220A (en) * 2011-06-13 2018-06-22 Medicago Inc Rabies virus like particle production in plants

Also Published As

Publication number Publication date
KR102211077B1 (en) 2021-02-02
KR20200089151A (en) 2020-07-24

Similar Documents

Publication Publication Date Title
EP3681514A4 (en) Zika virus rna vaccines
HK1255847A1 (en) Vaccines against hepatitis b virus
EP3609534A4 (en) Broad spectrum influenza virus vaccine
IL258833A (en) Herpes simplex virus vaccine
EP3365007A4 (en) Broad spectrum influenza virus vaccine
EP4004036A4 (en) Virus-like particle vaccines
GB202104898D0 (en) CpG-adjuvanted SARS-CoV-2 virus vaccine
EP3463447A4 (en) Influenza virus vaccination regimens
HK1259274A1 (en) Human respiratory syncytial virus (hrsv) virus-like particles (vlps) based vaccine
EP3419660A4 (en) Novel vaccines against zika virus
EP3247389A4 (en) Influenza virus vaccination regimens
EP3439696A4 (en) Therapeutic vaccine for hepatitis b virus (hbv) using the hbv core antigen
LT3355915T (en) Canine parvovirus (cpv) virus-like particle (vlp) vaccines and uses thereof
IL263550A (en) Vaccine against infectious bronchitis virus
EP3403671C0 (en) Vaccine containing immobilized virus particles
IL290924A (en) Hepatitis b virus vaccines
KR102211077B9 (en) - A pseudo type rabies virus vaccine using virus-like particles
EP3866847A4 (en) Virus vaccine
EP3347044A4 (en) Bird flu vaccine combination comprising virus-like particles and novel adjuvants
GB201910651D0 (en) Virus-like particle
EP3170509A4 (en) Vaccine containing virus-like particles
EP3247390A4 (en) Immunogenicity of an optimized synthetic consensus dna vaccine for porcine epidemic diarrhea virus
EP3545973A4 (en) Vaccine composition comprising hepatitis b virus-like particles as adjuvant
ZA202210419B (en) Influenza virus-like particles (vlps)
AU2018903913A0 (en) Virus Vaccine

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
G170 Publication of correction